Abstract:Although the use of bioresorbable materials in stent production is thought to improve long-term safety compared to their durable counterparts, a recent FDA report on the 2-year follow-up of the first FDA-approved bioresorbable vascular stent showed an increased occurrence of major adverse cardiac events and thrombosis in comparison to the metallic control. In order to overcome the issues of first generation bioresorbable polymers, a series of polyethylene glycol-functionalized poly-L-lactide-co-ε-caprolactone copolymers with varying lactide-to-caprolactone content is developed using a novel one-step PEG-functionalization and copolymerization strategy. This approach represents a new facile way toward surface enhancement for cellular interaction, which is shown by screening these materials regarding their cyto- and hemocompatibility in terms of cytotoxicity, hemolysis, platelet adhesion, leucocyte activation and endothelial cell adhesion. By varying the lactide-to-caprolactone polymer composition, it is possible to gradually affect endothelial and platelet adhesion which allows fine-tuning of the biological response based on polymer chemistry. All polymers developed were non-cytotoxic, had acceptable leucocyte activation levels and presented non-hemolytic (<2% hemolysis rate) behavior except for PLCL-PEG 55:45 which presented hemolysis rate of 2.5% ± 0.5. Water contact angles were reduced in the polymers containing PEG functionalization (PLLA-PEG: 69.8° ± 2.3, PCL-PEG: 61.2° ± 7.5) versus those without (PLLA: 79.5° ± 3.2, PCL: 76.4° ± 10.2) while the materials PCL-PEG550, PLCL-PEG550 90:10 and PLCL-PEG550 70:30 demonstrated best endothelial cell adhesion. PLLA-PEG550 and PLCL-PEG550 70:30 presented as best candidates for cardiovascular implant use from a cytocompatibility perspective across the spectrum of testing completed. Altogether, these polymers are excellent innovative materials suited for an application in stent manufacture due to the ease in translation of this one-step synthesis strategy to device production and their excellent in vitro cyto- and hemocompatibility.

Mechanical properties and in vivo performance of a novel sliding-lock bioabsorbable poly- p -dioxanone stent

3D-Printed Poly (P-Dioxanone) Stent for Endovascular Application: In Vitro Evaluations

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

Drug-Eluting Biodegradable Poly-D/L-Lactic Acid Vascular Stents: An Experimental Pilot Study

3D-Printed Bioresorbable Stent Coated with Dipyridamole-Loaded Nanofiber for Restenosis Prevention and Endothelialization

6-Month Follow-Up of a Novel Biodegradable Drug-Eluting Stent Composed of Poly-L-Lactic Acid and Amorphous Calcium Phosphate Nanoparticles in Porcine Coronary Artery.

Design and characterization of PLLA stents with Z-structure

Surface Patterning of a Novel PEG‐functionalized Poly‐l‐lactide Polymer to Improve Its Biocompatibility: Applications to Bioresorbable Vascular Stents

Bio-resorbable polymer stents: a review of material progress and prospects

Short-term Effects of Fully Bioabsorbable PLLA Coronary Stents in a Porcine Model

Computational and Experimental Investigation into Mechanical Performances of Poly-L-Lactide Acid (PLLA) Coronary Stents

[Penal liability from retained foreign body inside the surgical site].

Improved Mechanical Properties of Poly( L ‐lactic Acid) Stent Coated by Poly( D , L ‐lactic Acid) and Poly( L ‐lactic‐co‐glycolic Acid) Biopolymer Blend

Development and characterization of a coronary polylactic acid stent prototype generated by selective laser melting

A biodegradable polymer stent with high radial performance: Potential for treatment of portal vein stenosis

Long-term in vivo study of biodegradable Zn-Cu stent: A 2-year implantation evaluation in porcine coronary artery.

Long-Term Efficacy of Biodegradable Metal-Polymer Composite Stents after the First and the Second Implantations into Porcine Coronary Arteries

Hybrid interpenetrating network of polyester coronary stent with tunable biodegradation and mechanical properties

A novel biodegradable polymer coated,sirolimus-eluting stent: evaluation in a porcine coronary model

[Design and mechanical properties of biodegradable polymeric stent]

A Novel Paclitaxel Eluting Bioresorbable Coronary Stent 3D Printed from a Tougher and Faster Degradation Poly(L-Lactide-Co-Caprolactone) Co-Polymer